Tenet Healthcare Corporation (THC)
Tenet Healthcare (THC) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Will Tenet (THC) Beat Estimates Again in Its Next Earnings Report?
Tenet (THC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Top Health Care Stocks Beating the S&P 500 This Year
The health care space contains several market leaders that are widely outperforming.
Tenet Healthcare (THC) Advances While Market Declines: Some Information for Investors
Tenet Healthcare (THC) reachead $136.03 at the closing of the latest trading day, reflecting a +1.33% change compared to its last close.
Here's Why Tenet Healthcare (THC) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Fast-paced Momentum Stock Tenet (THC) Is Still Trading at a Bargain
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Tenet (THC) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Tenet Healthcare (THC) Stock Falls Amid Market Uptick: What Investors Need to Know
In the closing of the recent trading day, Tenet Healthcare (THC) stood at $136.88, denoting a -0.82% change from the preceding trading day.
Tenet Healthcare: Asset Sales, Current Multiples Support Re-Rating (Rating Upgrade)
THC stock has rallied in 2024 due to management's sale of underperforming assets, unlocking capital for high return opportunities. Management's focus on acute surgery centers and redeploying funds is grounds for potential multiple expansion. Revised estimates show potential for THC to reach a valuation range of $220-$250 per share, supporting a buy rating.
Wall Street Analysts Think Tenet (THC) Is a Good Investment: Is It?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Should Value Investors Buy Tenet Healthcare (THC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Tenet Healthcare (THC) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
